Convalescent plasma is of limited clinical benefit in critically ill patients with coronavirus disease-2019: a cohort study

Convalescent plasma is of limited clinical benefit in critically ill patients with coronavirus disease-2019: a cohort study

Abstract Background Recently, convalescent plasma (CP) transfusion was employed for severe or critically ill patients with coronavirus disease-2019. However, the benefits of CP for patients with different conditions are still in debate. To contribute clinical evidence of CP on critically ill patient...

Full description

Bibliographic Details
Main Authors: Li Huang, Che Zhang, Xihui Zhou, Zhou Zhao, Weiping Wang, Weidong Leng, Xiao Su, Qizhou Lian
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Journal of Translational Medicine
Subjects:
Convalescent plasma
Coronavirus
Coronavirus disease-2019
Mortality
SARS-CoV-2
Online Access:https://doi.org/10.1186/s12967-021-03028-5

Internet

https://doi.org/10.1186/s12967-021-03028-5

Similar Items